Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer

Clinical trial NCT04669197 · COMPLETED

Trial details

NCT number: NCT04669197
Sponsor: HonorHealth Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Untreated Resectable Pancreatic Adenocarcinoma Borderline Resectable Pancreatic Adenocarcinoma Locally Advanced Pancreatic Adenocarcinoma

Start date: 2020-12-01
Primary completion: 2024-02-21
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.